{"uniprot":"Q86U17","gene":"SERPINA11","name":"Serpin A11","organism":"Homo sapiens (Human)","status":"dark","length":422,"sequence":"MGPAWLWLLGTGILASVHCQPLLAHGDKSLQGPQPPRHQLSEPAPAYHRITPTITNFALRLYKELAADAPGNIFFSPVSISTTLALLSLGAQANTSALILEGLGFNLTETPEADIHQGFRSLLHTLALPSPKLELKVGNSLFLDKRLKPRQHYLDSIKELYGAFAFSANFTDSVTTGRQINDYLRRQTYGQVVDCLPEFSQDTFMVLANYIFFKAKWKHPFSRYQTQKQESFFVDERTSLQVPMMHQKEMHRFLYDQDLACTVLQIEYRGNALALLVLPDPGKMKQVEAALQPQTLRKWGQLLLPSLLDLHLPRFSISGTYNLEDILPQIGLTNILNLEADFSGVTGQLNKTISKVSHKAMVDMSEKGTEAGAASGLLSQPPSLNTMSDPHAHFNRPFLLLLWEVTTQSLLFLGKVVNPVAG","function_summary":"A human serpin-fold protein that assembles high-affinity macromolecular complexes to modulate signaling and gene-regulatory pathways tied to vascular and neural biology. Its metastable serpin core provides a versatile binding platform that restrains protease-driven cues and engages chromatin-associated partners, thereby dampening angiogenic programs while promoting neurogenic differentiation. The protein likely resides and matures within the endoplasmic reticulum, where it assembles with secretory-pathway factors and chaperones before influencing extracellular and intracellular targets through regulated binding and potential endopeptidase control.","plain_language":"SERPINA11 has barely been studied. The model's best guess: A human serpin-fold protein that assembles high-affinity macromolecular complexes to modulate signaling and gene-regulatory pathways tied to vascular and neural biology. Its metastable serpin core provides a versatile binding platform that restrains protease-driven cues and engages chromatin-associated partners, thereby dampening angiogenic programs while promoting neurogenic differentiation.","uniprot_summary":"May be involved in neurogenesis and inhibition of angiogenesis.","go_terms":{"molecular_function":[{"id":"GO:0005515","label":"protein binding"},{"id":"GO:0003677","label":"DNA binding"},{"id":"GO:0004867","label":"serine-type endopeptidase inhibitor activity"}],"biological_process":[{"id":"GO:0050769","label":"positive regulation of neurogenesis"},{"id":"GO:0016525","label":"negative regulation of angiogenesis"}],"cellular_component":[{"id":"GO:0005783","label":"endoplasmic reticulum"}]},"interpro":[{"id":"IPR036186","name":"Serpin superfamily","type":"homologous_superfamily","start":2,"end":419},{"id":"IPR042178","name":"Serpin superfamily, domain 1","type":"homologous_superfamily","start":57,"end":374},{"id":"IPR042185","name":"Serpin superfamily, domain 2","type":"homologous_superfamily","start":218,"end":313},{"id":"IPR023796","name":"Serpin domain","type":"domain","start":54,"end":419},{"id":"IPR000215","name":"Serpin family","type":"family","start":50,"end":419}],"reasoning":"I begin with the InterPro architecture. The sequence is dominated by serpin signatures: IPR036186 (Serpin superfamily, residues 2–419) blankets nearly the full length, while IPR023796 (Serpin domain, residues 54–419) and IPR000215 (Serpin family, residues 50–419) define the canonical serpin fold. Within this scaffold, IPR042178 (Serpin superfamily, domain 1, residues 57–374) and IPR042185 (Serpin superfamily, domain 2, residues 218–313) partition the core into subdomains that form the stressed-to-relaxed conformational trap typical of inhibitory serpins. The ordered layout—an N-terminal serpin core followed by internal subdomain refinements—creates a metastable β-sheet-rich platform that supports high-affinity macromolecular binding and, in inhibitory clades, suicide-substrate inhibition. In non-inhibitory serpins, the same fold is repurposed as a versatile binding module.\n\nThis serpin architecture causally explains three molecular functions. First, the broad serpin scaffold inherently mediates GO:0005515 protein binding through its exposed β-sheets and hinge that capture partners. Second, the conserved serpin fold can present basic patches and nucleic-acid–affine surfaces, rationalizing GO:0003677 DNA binding observed for several serpins that modulate transcriptional or chromatin-associated complexes. Third, the presence of the serpin inhibitory framework supports GO:0004867 serine-type endopeptidase inhibitor activity; even if this particular clade attenuates or forgoes classical inhibition, the fold still enables endopeptidase regulatory chemistry and often retains residual inhibitory capacity.\n\nFrom these molecular activities, I infer the biological processes. The serpin platform’s ability to bind and regulate proteases and signaling adaptors positions the protein to dampen pro-angiogenic signaling, aligning with GO:0016525 negative regulation of angiogenesis. In neural contexts, the same binding versatility can stabilize pro-differentiation assemblies and transcriptional programs, supporting GO:0050769 positive regulation of neurogenesis. The dual process annotations follow naturally from a modular binder that tunes extracellular signaling and intracellular gene-regulatory nodes.\n\nCellular localization follows from biosynthetic routing and binding context. The serpin fold is frequently secreted or luminal; here, the evidence points to GO:0005783 endoplasmic reticulum, consistent with folding, disulfide formation, and glycoprotein maturation that serpins often undergo. An ER-resident or ER-associated lifestyle enables surveillance of secretory protease pathways and provides a staging ground for assembly of regulatory complexes that ultimately influence angiogenesis and neurogenesis.\n\nMechanistically, I propose that the serpin scaffold acts as a luminal/ER-associated adaptor that binds proteases and their regulators to restrain angiogenic signaling, while also engaging nuclear or chromatin-associated partners that bias neural differentiation. Likely interaction partners include secretory-pathway serine proteases and their cofactors (e.g., trypsin-like endopeptidases), ER chaperones that shepherd folding (such as HSPA5/BiP and protein disulfide isomerases), and transcriptional regulators that mediate neurogenic programs. Through these assemblies, the serpin architecture enforces protease and signaling balance that manifests as inhibition of angiogenesis and promotion of neurogenesis.","category":"dark","control_evaluation":null,"validation_plan":null,"structure":{"source":"AlphaFold DB","pdb":"/structures/AF-Q86U17.pdb","alphafold":"https://alphafold.ebi.ac.uk/entry/Q86U17"},"links":{"uniprot":"https://www.uniprot.org/uniprotkb/Q86U17/entry","atlas":"/p/Q86U17"},"provenance":{"model":"BioReason-Pro (ESM3 esm3-sm-open-v1)","source_list":"Pharos Tdark","note":"AI prediction, not experimentally verified"}}